Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

ABBV

Abbvie Inc

Jun 13 • 04:00PM ET

166.56

Dollar change +0.47
Percentage change 0.28	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO SPY IVV VTV XLV SCHD VIG VYM IWF

Scroll to Statements

Index	S&P 500	P/E	49.59	EPS (ttm)	3.36	Insider Own	0.10%	Shs Outstand	1.77B	Perf Week	-1.19%
Market Cap	294.12B	Forward P/E	13.83	EPS next Y	12.04	Insider Trans	-20.73%	Shs Float	1.76B	Perf Month	3.08%
Income	5.95B	PEG	7.98	EPS next Q	3.05	Inst Own	72.56%	Short Float	0.93%	Perf Quarter	-8.08%
Sales	54.40B	P/S	5.41	EPS this Y	1.11%	Inst Trans	0.10%	Short Ratio	2.94	Perf Half Y	8.69%
Book/sh	4.53	P/B	36.73	EPS next Y	7.22%	ROA	4.20%	Short Interest	16.49M	Perf Year	20.43%
Cash/sh	10.23	P/C	16.28	EPS next 5Y	6.21%	ROE	55.92%	52W Range	130.96 - 182.89	Perf YTD	7.48%
Dividend Est.	6.18 (3.71%)	P/FCF	13.46	EPS past 5Y	-5.77%	ROI	8.29%	52W High	-8.93%	Beta	0.62
Dividend TTM	6.06 (3.64%)	Quick Ratio	0.83	Sales past 5Y	11.76%	Gross Margin	68.99%	52W Low	27.18%	ATR (14)	3.14
Dividend Ex-Date	Apr 12, 2024	Current Ratio	0.94	EPS Y/Y TTM	-21.01%	Oper. Margin	31.87%	RSI (14)	55.38	Volatility	1.71% 1.87%
Employees	50000	Debt/Eq	9.24	Sales Y/Y TTM	-4.12%	Profit Margin	10.94%	Recom	1.87	Target Price	183.82
Option/Short	Yes / Yes	LT Debt/Eq	7.97	EPS Q/Q	496.96%	Payout	220.33%	Rel Volume	0.65	Prev Close	166.09
Sales Surprise	3.19%	EPS Surprise	2.24%	Sales Q/Q	0.70%	Earnings	Apr 26 BMO	Avg Volume	5.60M	Price	166.56
SMA20	2.35%	SMA50	1.55%	SMA200	4.51%	Trades		Volume	3,690,807	Change	0.28%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-24	Upgrade	HSBC Securities	Hold → Buy	$185
May-17-24	Initiated	Cantor Fitzgerald	Overweight	$200
Jan-29-24	Upgrade	William Blair	Mkt Perform → Outperform
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Dec-11-23	Upgrade	Goldman	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Hold	$150
Oct-30-23	Upgrade	Barclays	Equal Weight → Overweight	$160 → $170
Oct-20-23	Resumed	UBS	Neutral	$157 → $150
Sep-29-23	Initiated	Raymond James	Outperform	$177
Jul-25-23	Initiated	William Blair	Mkt Perform
Jul-14-23	Initiated	HSBC Securities	Buy	$167
Apr-05-23	Downgrade	Argus	Buy → Hold
Mar-01-23	Initiated	Guggenheim	Buy	$172
Feb-22-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Feb-10-23	Upgrade	SVB Securities	Underperform → Market Perform	$135 → $153
Nov-18-22	Initiated	Credit Suisse	Outperform	$170
Nov-08-22	Downgrade	Societe Generale	Buy → Hold
Aug-01-22	Downgrade	Atlantic Equities	Overweight → Neutral	$178 → $162
May-23-22	Initiated	SVB Leerink	Underperform	$140
May-06-22	Downgrade	Daiwa Securities	Outperform → Neutral	$150

Show Previous Ratings

Today 04:12AM	AbbVie and FutureGen link on inflammatory bowel disease (Pharmaceutical Technology)
Jun-13-24 12:00PM	Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends (Benzinga)
09:05AM	AbbVie joins TL1A race via $150M upfront deal with China's FutureGen (FierceBiotech.com)
07:59AM	AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease (PR Newswire)
Jun-12-24 09:00AM	AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:00AM	Loading…
Jun-11-24 08:00AM	The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value (GuruFocus.com)
08:00AM	BOTOX Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients (PR Newswire)
Jun-10-24 05:45PM	AbbVie (ABBV) Laps the Stock Market: Here's Why (Zacks)
Jun-07-24 10:18AM	AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal (Zacks)
07:30AM	Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO (BioPharma Dive)
06:46AM	AbbVie reports positive Phase II ovarian cancer trial data (Clinical Trials Arena)
Jun-06-24 03:07PM	Final Trades: Amazon, Goldman Sachs, AbbVie and IQVIA Holdings (CNBC TV)
02:58PM	Medtronic plc (NYSE:MDT): The Best Healthcare Dividend Aristocrat Stock To Buy? (Insider Monkey)
02:44PM	Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts? (Insider Monkey)
02:25PM	25 Best Dividend Aristocrats to Buy According to Analysts (Insider Monkey)
11:53AM	Loading…
11:53AM	AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug (Zacks)
08:45AM	AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE) for High Folate Receptor-Alpha (FR) Expressing Platinum-Sensitive Ovarian Cancer (PR Newswire)
08:30AM	SkinMedica Celebrates 25 Years of Empowering Radiant Skin (PR Newswire)
08:00AM	AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers (PR Newswire)
06:19AM	7 Stocks That Could Safely 10X by 2030 (InvestorPlace)
06:00AM	Hedge Fund Favorites: 7 Stocks to Buy When You're Feeling Jittery (InvestorPlace)
04:45AM	AbbVie treats first subject in Phase III multiple myeloma drug trial (Clinical Trials Arena)
Jun-05-24 05:37PM	Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential (InvestorPlace)
10:00AM	Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses (Business Wire)
09:30AM	2 High-Yield Dividend Stocks to Buy Right Now (Motley Fool)
09:00AM	AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383 (PR Newswire)
07:55AM	Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks (BioPharma Dive)
07:30AM	The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme (InvestorPlace)
06:46AM	AbbVies RINVOQ now indicated for paediatric arthritis in US (Pharmaceutical Technology)
Jun-04-24 11:04AM	ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop (FierceBiotech.com)
10:43AM	Loading…
10:43AM	3 Dividend Stocks You May Want To Double Down On (Benzinga)
08:52AM	Top Stocks to Buy in June (Motley Fool)
08:30AM	RINVOQ (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis (PR Newswire)
08:05AM	Refer Your Friends to All, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50 (PR Newswire)
Jun-03-24 05:45PM	AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know (Zacks)
11:45AM	AbbVie (ABBV) Could Be a Great Choice (Zacks)
10:05AM	AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU (Zacks)
08:30AM	AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (PR Newswire)
06:00AM	7 Overlooked Stocks That Belong in Every Portfolio (InvestorPlace)
04:25AM	ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours (Clinical Trials Arena)
02:33AM	AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock? (Zacks)
Jun-02-24 06:00AM	3 No-Brainer Stocks to Buy in June (Motley Fool)
May-31-24 01:38PM	Final Trades: Lululemon, Sysco, Abbvie and TJX Companies (CNBC TV)
12:18PM	15 Most Profitable Biotechnology Companies in the World (Insider Monkey)
02:00AM	AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (PR Newswire)
May-30-24 08:02AM	CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
05:45AM	3 Dividend Stocks to Double Up on Right Now (Motley Fool)
May-29-24 04:32PM	Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock? (Zacks)
01:04PM	Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses (Business Wire)
09:00AM	AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-28-24 08:00AM	Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc (GuruFocus.com)
08:00AM	AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative Antibody-Drug Conjugate (ADC) Platform (PR Newswire)
May-27-24 12:32PM	7 Biotech Stocks to Put on Your Breakthrough Radar (InvestorPlace)
May-26-24 08:10AM	Forget Nvidia, Buy This Magnificent Healthcare Stock Instead (Motley Fool)
07:05AM	10 Best Dividend Aristocrat Stocks To Buy Now (Insider Monkey)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
05:46AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever (Motley Fool)
May-24-24 08:45AM	Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 (GlobeNewswire)
May-23-24 04:05PM	AbbVie Completes Acquisition of Landos Biopharma (PR Newswire)
02:01PM	3 Biotech Stocks to Buy on the Dip: May 2024 (InvestorPlace)
09:40AM	Why AbbVie (ABBV) is a Top Value Stock for the Long-Term (Zacks)
May-22-24 08:50PM	The 100%+ Club: Piper Sandler's 3 Top Picks for Triple-Digit Gains (InvestorPlace)
05:17PM	Top 20 Largest Publicly Traded Healthcare Companies (Insider Monkey)
10:24AM	Add These Dividend Stocks To Your Portfolio To Boost Your Retirement Income, Plus 2 High-Yield Alternatives (Benzinga)
09:48AM	7 Safe-Haven Stocks to Weather Any Storm (InvestorPlace)
08:42AM	A Must-Own Stock for Any Portfolio (Motley Fool)
06:45AM	2 Billion More Reasons to Buy AbbVie Stock (Motley Fool)
May-20-24 02:47PM	3 S&P 500 Stocks That Have Proven Themselves Recession-Proof (InvestorPlace)
10:58AM	1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165? (Motley Fool)
May-17-24 09:38AM	Robinhood upgraded, Baidu downgraded: Wall Street's top analyst calls (The Fly)
07:30AM	AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week (PR Newswire)
07:11AM	7 Value Stocks to Buy and Hold for a Decade of Dominance (InvestorPlace)
May-16-24 03:30PM	AbbVie CEO latest heavy hitter to buy in Boca Raton (The Real Deal)
06:00AM	Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
May-15-24 06:22AM	NeuroSense taps PhaseVs ML tech for Phase III ALS trial analysis (Clinical Trials Arena)
May-14-24 12:10PM	AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal (Zacks)
09:00AM	Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know (Zacks)
08:00AM	Unlocking Intrinsic Value: Analysis of AbbVie Inc (GuruFocus.com)
06:30AM	3 Magnificent Stocks That Are Passive Income Machines (Motley Fool)
May-13-24 04:51PM	AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh (FierceBiotech.com)
11:44AM	12 Undervalued Stocks That Just Raised Their Dividends (Insider Monkey)
11:09AM	What Is the Dividend Payout for AbbVie Stock? (Motley Fool)
09:34AM	AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders (MT Newswires)
08:39AM	AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders (PR Newswire)
May-11-24 08:38AM	Earn $1000 Every Month From These 3 Stocks (Motley Fool)
03:50AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. (Motley Fool)
May-10-24 12:59PM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:30AM	3 Rock-Solid Dividend Stocks That Are Ideal for Retirees (Motley Fool)
May-09-24 03:53PM	REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:11AM	Q1 2024 Regenxbio Inc Earnings Call (Thomson Reuters StreetEvents)
May-08-24 02:10PM	Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)
10:49AM	AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine (MT Newswires)
09:37AM	Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)
08:32AM	Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 (MT Newswires)
08:00AM	QULIPTA (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults (PR Newswire)
May-07-24 04:30PM	Teva Earnings Are Soon. What Could Keep the Stock Gains Going. (Barrons.com)
02:50PM	15 Best S&P 500 Dividend Stocks To Buy Now (Insider Monkey)
02:04PM	Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare (InvestorPlace)
10:24AM	Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-06-24 02:30PM	3 Biotech Stocks to Double Your Money in the Next 24 Months (InvestorPlace)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Donoghoe Nicholas	EVP, CHIEF BUS/STRAT OFFICER	Mar 20 '24	Sale	176.30	21,082	3,716,757	55,903	Mar 22 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 18 '24	Option Exercise	61.36	26,110	1,602,110	119,890	Mar 20 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 18 '24	Sale	178.79	58,949	10,539,508	60,941	Mar 20 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 01 '24	Option Exercise	61.36	45,700	2,804,152	89,517	Mar 05 05:30 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 01 '24	Sale	177.27	75,680	13,415,503	13,837	Mar 05 05:30 PM
Michael Robert A.	PRES & CHIEF OPERATING OFFICER	Feb 29 '24	Option Exercise	58.30	21,560	1,257,012	167,524	Mar 01 05:50 PM
Michael Robert A.	PRES & CHIEF OPERATING OFFICER	Feb 29 '24	Sale	176.45	68,879	12,153,957	98,645	Mar 01 05:50 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 29 '24	Sale	177.39	9,891	1,754,555	10,397	Mar 01 05:50 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 29 '24	Sale	176.65	5,144	908,688	6,983	Mar 01 05:50 PM
GONZALEZ RICHARD A	CHAIRMAN OF THE BOARD AND CEO	Feb 28 '24	Sale	177.27	138,616	24,572,458	519,099	Mar 01 05:50 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 23 '24	Option Exercise	137.36	13,753	1,889,115	41,926	Feb 27 05:10 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Feb 23 '24	Option Exercise	61.36	14,140	867,630	41,205	Mar 01 05:50 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Feb 23 '24	Sale	177.44	14,140	2,509,002	27,065	Mar 01 05:50 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 23 '24	Sale	177.51	13,753	2,441,295	28,173	Feb 27 05:10 PM
SALEKI-GERHARDT AZITA	EVP, CHIEF OPERATIONS OFFICER	Feb 21 '24	Option Exercise	58.88	52,870	3,112,986	296,814	Feb 23 05:00 PM
SALEKI-GERHARDT AZITA	EVP, CHIEF OPERATIONS OFFICER	Feb 21 '24	Sale	173.71	52,870	9,184,048	243,944	Feb 23 05:00 PM
Donoghoe Nicholas	EVP, CHIEF BUS/STRAT OFFICER	Dec 26 '23	Sale	154.72	2,912	450,545	55,903	Dec 28 05:00 PM
GONZALEZ RICHARD A	CHAIRMAN OF THE BOARD AND CEO	Aug 01 '23	Sale	148.58	60,000	8,914,800	565,294	Aug 02 05:07 PM
GONZALEZ RICHARD A	CHAIRMAN OF THE BOARD AND CEO	Jul 31 '23	Sale	149.15	18,500	2,759,275	625,294	Aug 02 05:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABBV

Abbvie Inc

Upgrade your FINVIZ experience